TGF-β signaling in cancer metastasis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
The transforming growth factor (TGF)-β signaling events are well known to control diverse processes and numerous responses, such as cell proliferation, differentiation, apoptosis, and migration. TGF-β signaling plays context-dependent roles in cancer: in pre-malignant cells TGF-β primarily functions as a tumor suppressor, while in the later stages of cancer TGF-β signaling promotes invasion and metastasis. Recent studies have also suggested that the cross-talk between TGF-β signaling and other signaling pathways, such as Hippo, Wnt, EGFR/RAS, and PI3K/AKT pathways, may substantially contribute to our current understanding of TGF-β signaling and cancer. As a result of the wide-ranging effects of TGF-β, blockade of TGF-β and its downstream signaling components provides multiple therapeutic opportunities. Therefore, the outlook for anti-TGF-β signaling therapy for numerous diseases appears bright and will provide valuable information and thinking on the drug molecular design. In this review, we focus on recent insights into the regulation of TGF-β signaling in cancer metastasis which may contribute to the development of novel cancer-targeting therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, cancer cells adapt to the protective TGF‐β signaling and utilize its moonlighting functions to create a conducive TME by activating CAFs, promoting angiogenesis and ECM production, and suppressing anti‐tumor immune responses [160, 161, 162].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [162]
Citations
Cites
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654 · cited 1×
“LncRNAs can regulate many important cancer-associated phenotypes, including proliferation, apoptosis, or cell migration, through their interactions with DNA, chromatin, signaling and regulatory proteins, and a variety of cellular RNA species [74,75].”
BackgroundSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218 · cited 1×
“The HOX-associated lncRNA HOTAIR can reprogram the chromatin landscape genomewide via recruitment of polycomb repressive complex 2 (PRC2), leading to increased breast cancer invasiveness and metastasis [87].”
BackgroundTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · cited 1×
“Certain tumors produce metastasis to specific organs independent of vascular anatomy, rate of blood flow, and the number of tumor cells delivered to each organ, and this organotropic metastasis depends on the extracellular vesicles such as exosomal integrins α6β4 and α6β1 [62].”
BackgroundEvolution and Functions of Long Noncoding RNAs
Ponting, C. P., Oliver, P. L., & Reik, W. (2009) · Cell · doi:10.1016/j.cell.2009.02.006 · Cited by 4,208 · cited 1×
“LncRNAs can regulate many important cancer-associated phenotypes, including proliferation, apoptosis, or cell migration, through their interactions with DNA, chromatin, signaling and regulatory proteins, and a variety of cellular RNA species [74,75].”
BackgroundTumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863 · cited 1×
“The miR-200 family has been identified to repress EMT and tumor invasion by targeting the 3′ UTRs of the zinc-finger E-box binding factors 1 and 2 (ZEB1/2) [84,85].”
BackgroundMassagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Long non-coding RNAs: new players in cell differentiation and development
Fatica, A., & Bozzoni, I. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3606 · Cited by 2,980 · cited 1×
“LncRNA BRAF (V600E) regulates melanoma cell migration and lncRNA GAPLINC regulates CD44dependent cell invasiveness [78,79].”
Background
Cited by
Items 201–256 of 256
Study Progress on TGF-β Promoting the Development of Pancreatic Cancer
刘, 蔚. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12121644 · Cited by 2
Cytokine Plasma Levels in Breast Cancer Patients, Before and After Surgery
Kontomanolis, E. N., Tsigalou, C., Mitrakas, A. G., Gkegka, A. G., Efraimidou, E., Karamanidis, D., Nikoletos, K., Panagiotis, T., Nikolettos, N., Giatromanolaki, A. N., et al. (2024) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2023.0157 · Cited by 2
“…that are rather related to antitumor response, TGF-b is a potent immunosuppressive cytokine with direct effects on cancer cell growth, epithelial-to-mesenchymal transition, and also effects on intratumoral angiogenesis and metastasis (Hao et al., 2019; Xie et al., 2018; Yang and Moses, 2008).”
Detection of MicroRNAs Using Synthetic Toehold Switch in Mammalian Cells
Zhao, Y., Poudel, P., & Wang, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3718-0_16 · Cited by 2
Immune profile focusing on B-cell activating factor in B-cell malignancies
Tagami, N., Yamagishi, J., Fujii, W., Sanjoba, C., & Goto, Y. (2025) · Frontiers in Hematology · doi:10.3389/frhem.2025.1626886 · Cited by 2
Wang, Z., Huang, H., Huang, K., Cui, X., Wu, L., Lin, R., Zhao, Z., Chen, H., Cheng, Z., Jin, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202509695 · Cited by 2
Proteomic Findings in ADHD: A Systematic Review
Karabulut, O. B., & Ünal, D. (2025) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70057 · Cited by 2
Modulatory effects of Momordica balsamina on Th1/Th2 cytokine profiles in immune-challenged rats
Iman, H. A., Bashier, O., Maowia, M. M., & Elsheikh, H. A. (2019) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2019.6788 · Cited by 2
Systemic Therapy for Vascular Anomalies and the Emergence of Genotype-Guided Management
Nicholson, C. L., & Maguiness, S. (2022) · Dermatologic Clinics · doi:10.1016/j.det.2021.12.009 · Cited by 2
Jiang, D., Li, Y., Xu, Z., & Li, Y.-R. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.050125 · Cited by 2
Multifaceted modeling of small intestinal neuroendocrine tumors
Andrews, S. G., Forsythe, S. D., Madigan, J. P., & Sadowski, S. M. (2024) · Endocrine Oncology · doi:10.1530/eo-24-0038 · Cited by 2
Zelanis, A., Barcick, U., Racorti, N. D. V., & Salardani, M. D. S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200243 · Cited by 2
Ratnawati, H., Wargasetia, T. L., Larissa, L., ALVITRI, L., & BRYANT, K. (2024) · Experimental Oncology · doi:10.15407/exp-oncology.2024.01.022 · Cited by 2
“In contrast, tumor cells can resist its antimitogenic effects in the ad vanced phase, and TGFβ can switch into a tumor promoter [15, 21].”
BackgroundCarvalho, M. I., Silva-Carvalho, R., Prada, J., Pinto, C., Gregório, H., Lobo, L., Pires, I. C. R., & QUEIROGA, F. L. (2024) · Veterinary Quarterly · doi:10.1080/01652176.2024.2390941 · Cited by 2
“For instance, the dysregulation of TGFβ pathways in breast cancer have been correlated with disease progression, allowing cancer cells to warrant their own survival (Dumont and Arteaga 2000; Chen et al. 2016; Juang et al. 2016; Xie et al. 2018).”
BackgroundRahmasari, N., Barliana, M. I., & Amalia, R. (2021) · Indonesian Journal of Clinical Pharmacy · doi:10.15416/ijcp.2021.10.1.62 · Cited by 2
Wang, J., Zhou, M., Chen, F., Liu, X., Gao, J., Wang, W., Wang, H., & Yu, H. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3134 · Cited by 2
Rabêlo, A. C. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2020.tde-28012021-182303 · Cited by 2
Holographic Cell Stiffness Mapping Using Acoustic StimulationPreprint
Varol, R., Omeroglu, S., Karavelioğlu, Z., Aydemir, G., Karadag, A., Meco, H. E., Calibasi‐Kocal, G., Oruc, M. E., Esmer, G. B., Başbınar, Y., et al. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.07480 · Cited by 2
Chan, T. E. H., Islam, M. S., Fotouhi, O., Bozkurt, M., Nizamuddin, S., Schüle, K. M., Arnold, S. J., & Timmers, H. T. M. (2026) · Genes & Development · doi:10.1101/gad.353313.125 · Cited by 2
Niu, L., Wang, Y., Gao, Y., & Zhang, J. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1690932 · Cited by 1
“Moreover, TGF-β signaling can also affect other important biological signaling pathways, including Erk, Wnt, SAPK/JNK, PI3K/AKT, and p38 MAPK pathways (Xie et al., 2018).”
Skorkina, M., Kovaleva, T. F., Predeina, I., Smirnov, N., & Mukhina, I. V. (2026) · Cells · doi:10.3390/cells15040324 · Cited by 1
Almurshidi, B. (2020) · Scholar Commons (University of South Carolina) · Cited by 1
Molecular mechanisms of osteotropic cancer metastasis (literature review)
Kovalyova, I. V., Спирина, Л. В., Gorbunov, A. K., & Usynin, E. A. (2021) · Medical alphabet · doi:10.33667/2078-5631-2020-38-41-45 · Cited by 1
Identification of WWTR1 as an immune infiltration-correlated prognostic biomarker in colon cancer
Liu, X., Ge, J., Tian, L., Zhang, J., wang, R., Liu, X., Ding, Y., Lu, G., & Yin, X. (2022) · Medical Data Mining · doi:10.53388/mdm20220520011 · Cited by 1
Yu, J. X., Zhang, W., Ma, Q., & Gao, Y. (2022) · Science of Advanced Materials · doi:10.1166/sam.2022.4252 · Cited by 1
Молекулярные механизмы развития костных метастазов (обзор литературы)
А., К. И., В., С. Л., К., Г. А., & А., У. Е. (2020) · Medical alphabet · Cited by 1
GPD1L Suppresses Colon Adenocarcinoma Via Repressing TGFβ1/EMTPreprint
Li, Y., Liu, M., Xiang, Z., Yang, X., & Liu, H. (2021) · Research Square · doi:10.21203/rs.3.rs-1120400/v1 · Cited by 1
Pan-cancer study on transition of signaling systems from primary to metastatic tumorsPreprint
Zhou, W., & Zhang, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.11.619269 · Cited by 1
Agius, L. M. (2018) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2018.08.555748
TGF-ß and Tyrosine Kinases: Context in Colorectal Cancer
Konduru, S. K. P., & Muppala, S. (2018) · Springer eBooks · doi:10.1007/978-981-13-1486-5_13
Propofol inhibits proliferation and invasion of endometriotic cells by miR-9-5p/TGFBI axis
Li, G., Zhou, Q. Y., Song, J., Xiao, L., Zhu, Y., & Hou, B. (2020) · All Life · doi:10.1080/26895293.2020.1789761
Gao, S., Zhang, Z., Wang, X., Ma, Y., Li, C., Liu, H., Jing, C., Li, L., & Guo, X. (2021) · Research Square · doi:10.21203/rs.3.rs-885737/v2
Galunisertibe atenua a transição glial-mesenquimal em células gliais de Müller.
da Silva, R. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2022.tde-22082023-101649
Immune system in resistance prediction
Bahhar, İ., & Karakaş, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21790-6.00016-x
Liu, Y., Wang, R., Han, B., Zhu, B., Ma, Y., Yu, Y., Bai, L., Wei, Q., & Yang, P. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03432-8
A comprehensive outline of glioblastoma and molecular chemotherapy
Mishra, N., Soni, A., Rathod, A. V., & Singh, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33910-3.00013-3
Xu, J., Ma, L., Wang, D., & Yang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19588674
Caracterización Molecular de Cáncer Colorrectal Metacrónico
Tapial, S. (2020) · Library Open Repository (Universidad Complutense Madrid)
김채영 (2023) · Seoul National University Open Repository (Seoul National University)
Borzone, F. R., Giorello, M. B., Freire, A., Martinez, L. M., Feldman, L. J., Dimase, F., Evelson, P., Larripa, I. B., Batagelj, E., Cid, M. G., et al. (2026) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2026.074321
Faletti, S., Richichi, C., Osti, D., Ceccacci, E., Bertalot, G., Cerutti, C., Giardina, G., Marinaro, A., Costanza, B., Gambino, V., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505789
Rôle de la voie de signalisation Hippo dans le développement des ostéosarcomes
Morice, S. (2019) · theses.fr (ABES) · doi:10.70675/32829b80z5982z4f52z949bz98b3ed38b7c0
Monocyte-Macrophage Lineages in Cancer: Biology, Plasticity, and Therapeutic Targeting
Owusu, C., & Moles, R. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i2.23
Polymeric Gene Delivery Systems: Design Principles for Targeting Oncogenic Pathways
Jahanbekam, S., Aldhafeeri, B., Alipour, S., & Varamini, P. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00085
Advances in the understanding and nanocarrier-based management of triple-negative breast cancer
Sharma, A., Sharma, A., Singh, R. P., Jhawat, V., & Gulia, M. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102552
CRISPR approaches: Modeling tumor-stroma interactions and their role in cancer progression
Raninga, B., & Gupta, P. S. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102569
Aminzare, F., Mansoubi, S., Tooranposhti, Z. Z., & Mohsenpour, M. (2025) · Archives of Razi Institute · doi:10.66224/ari.80.6.3686
Kostro, P., Wolszczak-Biedrzycka, B., Kostro, E., Matowicka-Karna, J., Kamocki, Z. K., Pawlukianiec, C., Maciejczyk, M., Zalewska, A., & Dorf, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1889074
Feng, K., Qin, M., Peng, P., Yang, W., Pan, X., Tan, Y., Yang, S., Huang, J., & Zhang, J. (2026) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2026.2026-7-40
Samemaleki, S., Orooji, N., Kazemi, T., & Solgi, G. (2026) · PubMed Central · doi:10.22034/ibj.30.4.234
Франциянц, Е. М., Surikova, E. I., Бандовкина, В. А., Кодониди, И. П., Glushko, A. A., Chiriapkin, A., Поздняков, Д. И., Шихлярова, А. И., Алексеев, Э. К., Шалашная, Е. В., et al. (2026) · Современные проблемы науки и образования · doi:10.17513/spno.34731
Chen, Y., Wang, B., Chen, Y., Wu, Q., Lai, W.-F., Wei, L., Nandakumar, K. S., & Liu, D. (2022) · doi:10.3389/fimmu.2022.888612.s001
Xie, Z., Zhong, C., & Duan, S. (2022) · doi:10.3389/fcell.2022.809132.s001
Marguier, A., Laheurte, C., Lecoester, B., Malfroy, M., Boullerot, L., Renaudin, A., Seffar, E., Kumar, A., Nardin, C., Aubin, F., et al. (2022) · doi:10.3389/fimmu.2022.932298.s002
Metadata
- Authors
- Xie, F., Ling, L., Van Dam, H., Zhou, F., & Zhang, L.
- Affiliations
- Soochow University (CN)
- Zhejiang University (CN)
- Venue
- Acta Biochimica et Biophysica Sinica
- Published
- 2018-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 121-132
- ISSN
- 1672-9145 (ISSN-L)
- OpenAlex
- W2770010368
- Cited by
- 231
- References
- 125
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 29 · 2023: 32 · 2022: 46 · 2021: 40 · 2020: 32 · 2019: 20 · 2018: 5
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Biochimica et Biophysica Sinica (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- The National Basic Research Program of China (2016YFA0502500)
- National Natural Science Foundation of China (31471315, 31671457, 31571460, 31701232)
- The National Science Foundation for Post-doctoral Scientists of China (BX201700165)
- Zhejiang Natural Science Foundation (R14C070002)
- Jiangsu Natural Science Foundation (BK20150354)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- TGF-beta signaling, metastasis, tumor suppressor function, tumor invasion, signaling crosstalk, Hippo signaling pathway, Wnt signaling, PI3K/Akt signaling, anti-TGF-beta therapy
- MeSH terms
- Antineoplastic Agents, Humans, Models, Biological, Neoplasm Metastasis, Neoplasms, Signal Transduction, Transforming Growth Factor beta, Disease Progression, Tumor Suppressor Proteins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.